Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Capo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Science Translational Medicine|October 13, 2017
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1Giulia Schiroli, Samuele Ferrari, Anthony Conway, et al.
Frontiers in Endocrinology|September 24, 2024
Correction of osteopetrosis in the neonate <i>oc/oc</i> murine model after lentiviral vector gene therapy and non-genotoxic conditioningSara Penna, Alessandra Zecchillo, Martina Di Verniere, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2017
Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulationValentina Capo, Maria Carmina Castiello, Elena Fontana, et al.
Frontiers in Immunology|November 29, 2023
Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying <i>Rag1</i> hypomorphic mutationsMaria Carmina Castiello, Martina Di Verniere, Elena Draghici, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2019
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indicesStephen R Daley, Hui-Fern Koay, Kerry Dobbs, et al.
Nature|May 28, 2025
In vivo haemopoietic stem cell gene therapy enabled by postnatal traffickingMichela Milani, Anna Fabiano, Marta Perez-Rodriguez, et al.
Haematologica|January 18, 2020
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosisValentina Capo, Sara Penna, Ivan Merelli, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Science Translational Medicine|October 13, 2017
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1Giulia Schiroli, Samuele Ferrari, Anthony Conway, et al.
Frontiers in Endocrinology|September 24, 2024
Correction of osteopetrosis in the neonate <i>oc/oc</i> murine model after lentiviral vector gene therapy and non-genotoxic conditioningSara Penna, Alessandra Zecchillo, Martina Di Verniere, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2017
Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulationValentina Capo, Maria Carmina Castiello, Elena Fontana, et al.
Frontiers in Immunology|November 29, 2023
Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying <i>Rag1</i> hypomorphic mutationsMaria Carmina Castiello, Martina Di Verniere, Elena Draghici, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2019
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indicesStephen R Daley, Hui-Fern Koay, Kerry Dobbs, et al.
Nature|May 28, 2025
In vivo haemopoietic stem cell gene therapy enabled by postnatal traffickingMichela Milani, Anna Fabiano, Marta Perez-Rodriguez, et al.
Haematologica|January 18, 2020
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosisValentina Capo, Sara Penna, Ivan Merelli, et al.
Pageof 2